Trademarkia Logo

Canada

C$
VYEPTI CONVENA
ADVERTISED

on 26 Mar 2025

Last Applicant/ Owned by

H. Lundbeck A/S

Ottiliavej 9Valby, 2500

DK

Serial Number

2184550 filed on 10th May 2022

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

VYEPTI CONVENA

Trademark usage description

pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervou Read More

Classification Information


Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely cerebral palsy, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, central nervous system movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and alcohol dependency, headaches, migraines, pain, immune and inflammatory disorders and diseases, namely, autoimmune diseases, immunologic deficiency syndromes, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, inflammatory pelvic diseases; preparations, substances, reagents and agents for diagnostic and medical purposes, namely, medical diagnostic reagents.


Classification kind code

11

Class [010]
Surgical and medical apparatus and instruments, namely, knives for surgical use, lasers for surgical and medical use, medical and surgical catheters, medical and surgical laparoscopes, surgical clamps, surgical drills, surgical instruments, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes; medical devices, namely, syringes and pumps for administering drugs, syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposes, namely, test kits comprised of medical instruments for general examination for testing neurological diseases, namely, cerebral palsy, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, central nervous system movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; apparatus and instruments, namely, medical instruments for general examination for use with diagnosing, managing, surveying, assessing, controlling and examining psychological and neurological disorders and diseases, namely, cerebral palsy, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, central nervous system movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency ; integrated medical instruments for managing, measuring, surveying assessing, controlling, collecting, storing, transmitting and examining patient and client data and information picked up by the medical system, namely, integrated medical systems containing medical apparatus, namely, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators, dispensers, namely, aerosol dispensers for medical purposes, needles, syringes featuring software for information storage, information management, and for accessing information in the fields of neurology, neurological diseases and disorders, and brain diseases and disorders for use in Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments, namely, medical instruments for general examination, drainage tubes, electrodes, incubators, injection needles, irrigators, guide wires, respirators for collecting information to assist with medical professionals with guidance, management and control of patient medicines.


Classification kind code

11

Mark Details


Serial Number

2184550

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 26th Mar 2025
Advertised
Submitted for opposition 26
on 27th Feb 2025
Approved
Submitted for opposition 27
on 27th Feb 2025
Approval Notice Sent
Submitted for opposition 22
on 26th Mar 2024
Search Recorded
Submitted for opposition 20
on 26th Mar 2024
Examiner's First Report
Submitted for opposition 67
on 7th Oct 2022
Agent Name Changed
Submitted for opposition 287
on 19th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 10th May 2022
Filed
Submitted for opposition 1
on 10th May 2022
Created
Submitted for opposition 31
on 10th May 2022
Formalized